Placenta accreta spectrum-a catastrophic situation in obstetrics
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Placenta accreta is a significant obstetric complication in which the placenta is completely or focally adherent to themyometrium. The worldwide incidence of placenta accreta spectrum (PAS) is increasing day by day, mostly due tothe increasing trends in cesarean section rates. The accurate and timely diagnosis of placenta accreta is important toimprove the feto-maternal outcome. Although standard ultrasound is a reliable and primary tool for the diagnosis ofplacenta accreta, the absence of ultrasound findings does not preclude the diagnosis of placenta accreta. Therefore,clinical evaluation of risk factors is equally essential for the prediction of abnormal placental invasion. Pregnantwomen with a high impression or established diagnosis of placenta accreta should be managed by a multidisciplinaryteam in a specialist center. Traditionally, PAS has been managed by an emergency obstetric hysterectomy. Previously,few studies suggested a satisfactory success rate of conservative management in well-chosen cases, whereas fewstudies recommended delayed hysterectomy to reduce the amount of bleeding. The continuously increasing trends ofPAS and the challenges for its routine management are the main motives behind this literature review.
Abstract
Placenta accreta is a significant obstetric complication in which the placenta is completely or focally adherent to themyometrium. The worldwide incidence of placenta accreta spectrum (PAS) is increasing day by day, mostly due tothe increasing trends in cesarean section rates. The accurate and timely diagnosis of placenta accreta is important toimprove the feto-maternal outcome. Although standard ultrasound is a reliable and primary tool for the diagnosis ofplacenta accreta, the absence of ultrasound findings does not preclude the diagnosis of placenta accreta. Therefore,clinical evaluation of risk factors is equally essential for the prediction of abnormal placental invasion. Pregnantwomen with a high impression or established diagnosis of placenta accreta should be managed by a multidisciplinaryteam in a specialist center. Traditionally, PAS has been managed by an emergency obstetric hysterectomy. Previously,few studies suggested a satisfactory success rate of conservative management in well-chosen cases, whereas fewstudies recommended delayed hysterectomy to reduce the amount of bleeding. The continuously increasing trends ofPAS and the challenges for its routine management are the main motives behind this literature review.
참고문헌 (56)
- Jauniaux E, "FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology", Int J Gynecol Obstet, 140, pp.265~273 (2018)
- Mittal P, "Comparison of placenta accreta spectrum disorders diagnosed in intrapartum and antepartum period-a three year experience in a tertiary referral unit of India", Eur J Obstet Gynecol Reprod Biol, 236, pp.41~45 (2019)
- Solheim KN, "The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality", J Matern Fetal Neonatal Med, 24, pp.1341~1346 (2011)
- Fitzpatrick KE, "The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study", BJOG, 121, pp.62~71 (2014)
- Thurn L, "Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion:results from a large population-based pregnancy cohort study in the Nordic countries", BJOG, 123, pp.1348~1355 (2016)
- Bowman ZS, "Accuracy of ultrasound for the prediction of placenta accreta", Am J Obstet Gynecol, 211, pp.177~ (2014)
- Eller AG, "Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care", Obstet Gynecol, 117(2 Pt 1), pp.331~337 (2011)
- Shamshirsaz AA, "Multidisciplinary team learning in the management of the morbidly adherent placenta : outcome improvements over time", Am J Obstet Gynecol, 216, pp.612~ (2017)
- Shamshirsaz AA, "Outcomes of planned compared with urgent deliveries using a multidisciplinary team approach for morbidly adherent placenta", Obstet Gynecol, 131, pp.234~241 (2018)
- Bailit JL, "Morbidly adherent placenta treatments and outcomes", Obstet Gynecol, 125, pp.683~689 (2015)
- Higgins MF, "Real increasing incidence of hysterectomy for placenta accreta following previous caesarean section", Eur J Obstet Gynecol Reprod Biol, 171, pp.54~56 (2013)
- Silver RM, "Maternal morbidity associated with multiple repeat cesarean deliveries", Obstet Gynecol, 107, pp.1226~1232 (2006)
- Miller DA, "Clinical risk factors for placenta previa-placenta accreta", Am J Obstet Gynecol, 177, pp.210~214 (1997)
- Garmi G, "Epidemiology, eitiology, diagnosis and management of placenta accreta", Obstet Gynecol Int, 2012, pp.873929~ (2012)
- Baldwin HJ, "Antecedents of abnormally invasive placenta in primiparous women : risk associated with gynecologic procedures", Obstet Gynecol, 131, pp.227~233 (2018)
- Fitzpatrick KE, "Incidence and risk factors for placenta accreta", increta, PLoS One, pp.2012, 7[DOI]
- Hayashi M, "Adverse obstetric and perinatal outcomes of singleton pregnancies may be related to maternal factors associated with infertility rather than the type of assisted reproductive technology procedure used", Fertil Steril, 98, pp.922~928 (2012)
- Ishihara O, "Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single-embryo transfer cycles from 2008 to 2010 in Japan", Fertil Steril, 101, pp.128~133 (2014)
- Horcajadas JA, "Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles", Mol Hum Reprod, 11, pp.195~205 (2005)
- Kaser DJ, "Cryopreserved embryo transfer is an independent risk factor for placenta accreta", Fertil Steril, 103, pp.1176~1184 (2015)
- O’Brien JM, "The management of placenta percreta : conservative and operative strategies", Am J Obstet Gynecol, 175, pp.1632~1638 (1996)
- Ajah LO, "Placenta percreta in a booked multiparous woman with minimal risk factors and challenges of management in a low resource setting", Niger J Med, 21, pp.359~360 (2012)
- Jauniaux E, "Placenta accreta : pathogenesis of a 20th century iatrogenic uterine disease", Placenta, 33, pp.244~251 (2012)
- Randall S, "Placentation in the fallopian tube", Int J Gynecol Pathol, 6, pp.132~139 (1967)
- Godyn JJ, "Subperitoneal placenta accreta succenturiate in the case of a successful nearterm extrauterine abdominal pregnancy", Hum Pathol, 36, pp.922~926 (2005)
- Flo K, "Blood flow to the scarred gravid uterus at 22-24 weeks of gestation", BJOG, 121, pp.210~215 (2014)
- Jauniaux E, "Placenta accreta spectrum : pathophysiology and evidence-based anatomy for prenatal ultrasound imaging", Am J Obstet Gynecol, 218, pp.75~87 (2018)
- Fox H, "Placenta accreta : 1945-1969", Obstet Gynecol Surv, 27, pp.475~490 (1972)
- Benirschke K, "Pathology of the human placenta" (2012), Springer-Verlag
- Cahill AG, "American College of Obstetricians and Gynecologists. Placenta Accreta Spectrum", Am J Obstet Gynecol, 219, pp.B2~B16 (2018)
- Baughman WC, "Placenta accreta : spectrum of US and MR imaging findings", Radiographics, 28, pp.1905~1916 (2008)
- Jauniaux E, "Placenta praevia and placenta accreta:diagnosis and management: green-top guideline no. 27a", BJOG, 126, pp.e1~e48 (2019)
- D’Antonio F, "Prenatal identification of invasive placentation using ultrasound : systematic review and meta-analysis", Ultrasound Obstet Gynecol, 42, pp.509~517 (2013)
- D’Antonio F, "Prenatal identification of invasive placentation using magnetic resonance imaging : systematic review and meta-analysis", Ultrasound Obstet Gynecol, 44, pp.8~16 (2014)
- Reddy YS, "Lead and trace element levels in placenta, maternal and cord blood: a cross-sectional pilot study", J Obstet Gynaecol Res, 40, pp.2184~2190 (2014)
- S. Tinari, "Risk factors, histopathology and diagnostic accuracy in posterior placenta accreta spectrum disorders: systematic review and meta‐analysis", Ultrasound in Obstetrics & Gynecology, 57(6), pp.903~909 (2021), Wiley[DOI]
- Meyer NP, "Conservative approach to the management of morbidly adherent placentae", Ceylon Med J, 57, pp.36~39 (2012)
- American College of Obstetricians and Gynecologists, "ACOG practice bulletin no. 135: second-trimester abortion", Obstet Gynecol, 121, pp.1394~1406 (2013)
- Silver RM, "Placenta accreta spectrum: accreta, increta, and percreta", Obstet Gynecol Clin North Am, 42, pp.381~402 (2015)
- Eller AG, "Optimal management strategies for placenta accrete", BJOG, 116, pp.648~654 (2009)
- Warshak CR, "Effect of predelivery diagnosis in 99 consecutive cases of placenta accrete", Obstet Gynecol, 115, pp.65~69 (2010)
- Clark SL, "Hypogastric artery ligation for obstetric hemorrhage", Obstet Gynecol, 66, pp.353~356 (1985)
- Panigrahi AK, "A standardized approach for transfusion medicine support in patient with morbidly adherent placenta", Anesth Analg, 125, pp.603~608 (2017)
- Committee on Practice Bulletins-Obstetrics, "Practice bulletin no. 183: postpartum hemorrhage", Obstet Gynecol, 130, pp.e168~e186 (2017)
- Simonazzi G, "Tranexamic acid for preventing postpartum blood loss after cesarean delivery : a systematic review and meta-analysis of randomized controlled trials", Acta Obstet Gynecol Scand, 95, pp.28~37 (2016)
- Chandraharan E, "The triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta", Int J Gynaecol Obstet, 117, pp.191~194 (2012)
- Teixidor Viñas M, "Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta : a cohort study comparing outcomes before and after introduction of the triple-P procedure", Ultrasound Obstet Gynecol, 46, pp.350~355 (2015)
- Pinas-Carrillo A, "Outcomes of the first 50 patients with abnormally invasive placenta managed using the"triple P procedure"conservative surgical approach", Int J Gynaecol Obstet, 148, pp.65~71 (2020)
- Sentilhes L, "FIGO consensus guidelines on placenta accreta spectrum disorders : conservative management", Int J Gynecol Obstet, 140, pp.291~298 (2018)
- Ballas J, "Preoperative intravascular balloon catheters and surgical outcomes in pregnancies complicated by placenta accreta : a management paradox", Am J Obstet Gynecol, 207, pp.216.e1~216.e5 (2012)
- Tan CH, "Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta", AJR Am J Roentgenol, 189, pp.1158~1163 (2007)
- Salim R, "Precesarean prophylactic balloon catheters for suspected placenta accreta : a randomized controlled trial", Obstet Gynecol, 126, pp.1022~1028 (2015)
- Wu Q, "Outcome of pregnancies after balloon occlusion of the infrarenal abdominal aorta during caesarean in 230patients with placenta praevia accreta", Cardiovasc Intervent Radiol, 39, pp.1573~1579 (2016)
- Wang YL, "Comparison of temporary abdominal aortic occlusion with internal iliac artery occlusion for patients with placenta accreta-a non-randomised prospective study", Vasa, 46, pp.53~57 (2017)
- Fox KA, "Conservative management of morbidly adherent placenta : expert review", Am J Obstet Gynecol, 213, pp.755~760 (2015)
- Sawada M, "Successful conservative management of placenta percreta : investigation by serial magnetic resonance imaging of the clinical course and a literature review", J Obstet Gynaecol Res, 42, pp.1858~1863 (2016)
